Five Common Myths of Medical Malpractice Trials and Why We Should Not Be Afraid to Try Cases, 0121 SCBJ, SC Lawyer, January 2021, #40
Author | By John E. Hall, Jr., Lauren Spears Gresh and Jonathan Arndt |
Position | Vol. 24 Issue 4 Pg. 40 |
By John E. Hall, Jr., Lauren Spears Gresh and Jonathan Arndt
It is risky. It is volatile. It is expensive. They are unpredictable. They are sympathetic. They are unsophisticated. These are just some of the descriptors you hear in conversations and articles discussing medical malpractice trials and juries. Few things strike more fear into medical liability insurers than the prospect of taking a malpractice claim to trial. After all, it seems that a day rarely goes by without media coverage of another multi-million-dollar jury award to a plaintiff/ patient. But is the perception really all that it seems? We believe it is not. In fact, according to the Physician Insurers Association of America (PIAA), insurers prevail in 91% of the medical negligence claims that received a verdict between 2003 and 2012. Yet, still, only 8% of claims make it to the verdict stage of trial.
Why? Because almost all cases that are not dropped, withdrawn, or dismissed end in a plaintiff settlement. While there are certainly cases where settlement is appropriate for defendants—those cases where liability is indisputable—there are also cases where liability is more uncertain and settlement is sought nonetheless, which brings us back to fear.
The fear of trial stems from fear of uncertainty. Uncertainty lies with concerns regarding jurors and experts, awards and costs, which creates voids that are filled with perceptions of worst-case scenarios. Most common is the perception that jurors are sympathetic to plaintiffs, that they do not understand the science or medicine, and that they are downright unpredictable. There is also the perception that it costs too much to try a case and the result, if for the plaintiff, will likely be an astronomical award. But these perceptions are built upon myths that can be dispelled by data, and we argue that once they are put to bed, insurers can take advantage of the 91% success rate of trials and reduce overall indemnity at the same time.
Myth #1: Juries are sympathetic to plaintiffs
Insurers and defendant/physicians may be hesitant to take a medical malpractice case to trial because of the fear that jurors will be swayed by a sympathetic, injured plaintiff and perceive the physician or hospital as an evildoer with deep pockets. However, empirical research data contradicts this idea.
In a
2005 study, the latest available, from the U.S. Bureau of
Justice Statistics, there were an estimated 2,449 medical
malpractice cases tried before juries across the United
States.
These
figures show that juries do not make their decisions based
solely on their emotional attachment to an injured plaintiff.
In fact, a series of interviews with jurors from North
Carolina revealed that jurors —describe[] their
attitudes along two main themes: too many people want to get
something for nothing; and most doctors try to help people
and should not be blamed for simple human mis-judgment or a
momentary lapse of concentration.”
Likewise,
evidence does not support the idea that jurors render
verdicts for plaintiffs and against doctors or hospitals
simply because they perceive the doctor or hospital as having
the “deep pockets” to pay awards. In a study
conducted by Vidmar, 147 people called for jury duty were
asked to award damages for pain and suffering in a case where
the plaintiff suffered a broken leg as a result of
complications.
Based on the foregoing research, it is clear that jurors are generally skeptical of personal injury claims and are not likely to be influenced simply because a plaintiff appears sympathetic. Furthermore, juries are not likely to grant a plaintiff a large award simply because they believe that the hospital or doctor can afford to pay the damages.
Myth #2: Juries do not understand the science, so they side with plaintiffs and the guidance of their likeable experts
One common criticism of juries is that, because they are made up of laymen, the members are not always sophisticated enough to understand the science presented by medical experts in medical malpractice cases. Supposedly, this leads jurors to simply side with the party with the most likeable expert, rather than scrutinizing and analyzing the information presented to them. This in turn leads to fear of taking a case to trial, particularly cases involving very complex medicine. However, multiple studies have revealed data that contradicts this view.
One
study by Mark I. Taragin, MD, MPH and his colleagues used
data from closed claim files of a medical liability
insurer.
To continue reading
Request your trial